Person: Dr Alan Bernstein

Marc Lepage

Marc Lepage is returning to Canada to take the helm at Genome Quebec after spending seven years in the US. Lepage replaces interim president and CEO Denis Bilodeau, who stepped in following the departure of Jean-Marc Proulx last year. Lepage has had a long career in the public service including stints at the Medical Research…

Dr Alan Bernstein

Dr Alan Bernstein has been appointed president and CEO of the prestigious Canadian Institute for Advanced Research (CIFAR), effective May 1st. Bernstein replaces longstanding CIFAR head Chaviva Hosek, who announced more than one year ago that she was stepping down after 11 years (R$, December 13/10). Bernstein recently completed a five-year term as executive director…

Dr. Alan Bernstein

CIHR president comments on panel report
Dr. Alan Bernstein

Earlier this year, the Canadian Institutes of Health Research (CIHR), as required by its legislation and its commitment to accountability, underwent an open international review of our first five years of operation.

Dr. Alan Bernstein

Making the case for health research
Dr. Alan Bernstein

Accountability is the new buzzword in Ottawa. Today, like all investors, Canadians want evidence that their funds are being invested wisely and their investments are producing results.

Dr Alan Bernstein

Dr Alan Bernstein has been re-appointed to a second five-year term as president of the Canadian Institutes of Health Research. The appointment is subject to review by the Standing Committee on Health….

Paul Johnston

Paul Johnston has been appointed president and CEO of Precarn Inc, replacing Dr Anthony Eyton who is taking early retirement. Johnston is a 15-year veteran of Precarn, serving as its VP operations since 1997. Prior to that, he was network manager at the Institute for Robotics and Intelligent Systems, a Network of Centres of Excellence…

Dr Peter Munsche

Dr Peter Munsche is stepping down as assistant VP, technology transfer at the Univ of Toronto after 17 years. Munsche took up the position after serving for six years (1982-88) as executive director of the Canadian Institute for Advanced Research. While at U of T, he was founding chair of the Canadian University Intellectual Property…

Karimah Es Sabar

Karimah Es Sabar has been appointed executive director of BC Biotech, an association representing the province’s biotechnology industry. Es Sabar was most recently VP and COO of Medsurge Medical Inc. Prior to that, she was founder and managing director of SAL Healthcare Ltd, a marketing, distribution and consulting firm in Nairobi Kenya. Es Sabar holds…

Dr André Musy

Dr André Musy has been appointed DG of Ouranos, the research institute of Hydro-Québec. Musy comes to Ouranos from the École Polytechnique Fédérale de Lausanne (EPFL). His experience in hydrology, the environment and land and water use is well suited to Ouranos’ two-pronged research program of climate science/hydrology and impacts and adaptation strategies. Musy holds…